TGFB1 and systemic lupus erythematosus: Pretreated T cells with NPs loaded with IL-2/TGF-β further improved the survival rate of humanized SLE mice (8–12 weeks old NSG mice engrafted with 1×107 PBMCs/mouse from patients with SLE) compared to those of the non-treated T cell group (25).